4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001415889-24-022702
CEO AND CHIEF MEDICAL OFFICER bought 154,500 shares at an average $0.69 ($107,375)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 2024-08-29 | Purchase | +77,500 | $0.69 | $53,475 | 766,941 | D |
| Thye Dirk CEO AND CHIEF MEDICAL OFFICER | 2024-08-30 | Purchase | +77,000 | $0.70 | $53,900 | 843,941 | D |
| Open-market purchases · 154,500 sh · avg $0.69 · $107,375 | |||||||
Loading xslF345X05/form4-09032024_090940.xml…